Drug Trial Radar · NCT00484692
Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation
Last checked: Nov 20, 2026Latest source record: Jun 11, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
779
Actual
Start
Jul 2005
Primary completion
Not stated
Study completion Jan 2007
Sponsor
- Lead sponsor
- Medical University InnsbruckAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 11, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Background Smokers often reject drugs as smoking cessation aids. Nonpharmacological interventions are notoriously under-evaluated. Methods We conducted a randomized clinical trial in which we compared a medication, i.e., sustained-release bupropion (Zyban®; 413 subjects), at the time of the trial the most efficacious pharmacological smoking cessation aid, with an ultrashort psychotherapeutic intervention, Psychodynamic Model Training® (366 subjects), a manual-based psychodynamically oriented 1 ½ day autosuggestion training. Outcome criterion was 12-month self-reported continuous abstinence confirmed by urine cotinine levels below the level of detection (13 ng/ml) or, in an independent analysis, by exhaled carbon monoxide of 10 ppm or less at all interviews conducted at 3, 6, and 12 months.
Conditions
- Nicotine Dependence
- Substance Abuse
- Substance Dependence
- Tobacco Dependence
Interventions
sustained-release bupropion (Zyban(R))Drug
Psychodynamic Model Training (R) = PDM(R)Behavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Biochemically/pharmacologically-confirmed 12-month continuous abstinence as evidenced by self-reports of nonsmoking status in all interviews (i.e., at 3, 6, and 12 months)Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Institute for Clinical Psychology, Psychotherapy, and Health Promotion
Graz, Styria, Austria
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.